11β-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck

Clinical Otolaryngology and Allied Sciences

Volumn 27, Issue 6, 2002, Pages 453-457

  Gronau, Silke ^a   Greger, D Koenig ^a   Jerg, M ^a   Riechelmann, H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Detoxification; Head and neck cancer; NNK; RT PCR

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; CYTOCHROME P450 2D6; MESSENGER RNA; UNCLASSIFIED DRUG; HSD11B1 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE;

ADULT; ARTICLE; CANCER TISSUE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTATION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; ENZYMOLOGY; GENETICS; METABOLISM; OROPHARYNX TUMOR; PHARYNX; SMOKING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP2D6; HUMANS; HYDROXYSTEROID DEHYDROGENASES; OROPHARYNGEAL NEOPLASMS; PHARYNX; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, MESSENGER; SMOKING;

EID: 0036886311     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2002.00609.x     Document Type: Article

References (22)

1. Peto R., Darby S., Deo H. et al. (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. BMJ 321, 323-329
2. Department of Health Services (2000) Report on Carcinogens. 9, III 2-III, pp. 67-68
3. Hecht S.S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res. 424, 127-142
4. Upadhyaya P., Kenney P.M., Hochalter J.B. et al. (1999) Tumorgenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. Carcinogenesis 20, 1577-1582
5. Foiles P.G., Akerkar S.A., Carmella S.G. et al. (1991) Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and non-smokers. Chem. Res. Toxicol. 4, 364-368
6. Crespi C.L., Penman B.W., Gelboin H.V. et al. (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12, 1197-1201
7. Rannug A., Alexandrie A.K., Persson I. et al.. (1995) Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance. J. Occup. Environ. Med. 37, 25-36
8. Anwar W.A., Abdel-Rahman S.Z., El-Zein R.A. et al. (1996) Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17, 1923-1929
9. Saarikoski S.T., Sata F., Husgafvel-Pursiainen K. et al. (2000) CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. Pharmacogenetics 10, 5-10
10. Schulze J.R.E., Binder U. & Zwickenpflug B. (1992) Bilary excretion of 4-(methylnitrosamino)-1-(3-pyridil)-1-butanol in the rat. Carcinogenesis 13, 1961-1965.
11. Bush I.E., Hunter S.A. & Meigs R.A. (1968) Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver. Biochem. J. 107, 239-258
12. Seckle J. (1993) 11β-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur. J. Clin. Invest. 23, 589-601
13. Meger M.I.M.-K., Dietrich M., Tricker A. et al. (1996) Metabolites of 4-(methylnitrosamino)-1-(3-pyridil)-1-butanone in urine of smokers. Eur. J. Cancer Prev. (Suppl.) 1, 121-124
14. Maser E. & Bannenberg G. (1994) The purification of 11 beta-hydroxysteroid dehydrogenase from mouse liver microsomes. J. Steroid Biochem. Mol. Biol. 48, 257-263
15. Maser E., Richter E. & Friebertshauser J. (1996) The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur J. Biochem. 238, 484-489
16. Maser E. (1998) 11β-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridil)-1-butanone in mouse lung microsomes. Cancer Res. 58, 2996-3003
17. Soldan M., Nagel G., Losekam M. et al. (1999) Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung. Cancer Lett. 145, 49-56
18. Vineis P., Malats N., Lang M. et al. (1999) Metabolic Polymorphisms and Susceptibility to Cancer. IARC, Lyon
19. Dietz M., Ihrig A., Bader M. et al. (1999) Neurotoxic evaluation system for early diagnosis of solvent-associated effects in occupational medicine. Arbeitsmedzin, Sozialmedizin, Umweltmedizin 34, 185-193
20. Peto R., Lopez A.D., Boreham J. et al. (1996) Mortality from smoking world-wide. Br. Med. Bull. 52, 12-21
21. Smith T.J., Stoner G.D. & Yang C.S. (1997) Activation of 4-(methylnitrosamino)-1-(3-pyridil)-1-butanone (NNK) in human lung microsomes by cytochromes p450, lipoxygenase and hydroperoxides. Cancer Res. 55, 5566-5573
22. London S.J., Daly A.K., Leathart J.B. et al. (1997) Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis 18, 1203-1214